title: Options for T-cell based therapies.
authors.affiliation: Center for Gene and Cell Therapy, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital, Houston, Texas 77030, USA. hheslop@bcm.tmc.edu
authors.forename: H E
authors.initials: HE
authors.lastname: Heslop
authors.forename: S M
authors.initials: SM
authors.lastname: Gottschalk
authors.forename: C M
authors.initials: CM
authors.lastname: Bollard
authors.forename: K C M
authors.initials: KC
authors.lastname: Straathof
authors.forename: M H
authors.initials: MH
authors.lastname: Huls
authors.forename: M K
authors.initials: MK
authors.lastname: Brenner
authors.forename: C M
authors.initials: CM
authors.lastname: Rooney
mesh_terms: D000941:Antigens / Q000737:chemistry; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D003587:Cytomegalovirus / Q000235:genetics*; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007239:Infections / Q000821:virology; D009369:Neoplasms / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism
chemical_list: D000941:Antigens